JP2011508790A5 - - Google Patents

Download PDF

Info

Publication number
JP2011508790A5
JP2011508790A5 JP2010542439A JP2010542439A JP2011508790A5 JP 2011508790 A5 JP2011508790 A5 JP 2011508790A5 JP 2010542439 A JP2010542439 A JP 2010542439A JP 2010542439 A JP2010542439 A JP 2010542439A JP 2011508790 A5 JP2011508790 A5 JP 2011508790A5
Authority
JP
Japan
Prior art keywords
medical device
implantable medical
bioactive agent
powder
clonidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010542439A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011508790A (ja
JP5197763B2 (ja
Filing date
Publication date
Priority claimed from US12/410,151 external-priority patent/US8557273B2/en
Application filed filed Critical
Publication of JP2011508790A publication Critical patent/JP2011508790A/ja
Publication of JP2011508790A5 publication Critical patent/JP2011508790A5/ja
Application granted granted Critical
Publication of JP5197763B2 publication Critical patent/JP5197763B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010542439A 2008-04-18 2009-04-17 生物活性薬剤を含有するポリマーを含む医療用デバイスおよび方法 Active JP5197763B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4621308P 2008-04-18 2008-04-18
US61/046,213 2008-04-18
US12/410,151 2009-03-24
US12/410,151 US8557273B2 (en) 2008-04-18 2009-03-24 Medical devices and methods including polymers having biologically active agents therein
PCT/US2009/040916 WO2009129439A2 (en) 2008-04-18 2009-04-17 Medical devices and methods including polymers having biologically active agents therein

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013011995A Division JP5693623B2 (ja) 2008-04-18 2013-01-25 生物活性薬剤を含有するポリマーを含む医療用デバイスおよび方法

Publications (3)

Publication Number Publication Date
JP2011508790A JP2011508790A (ja) 2011-03-17
JP2011508790A5 true JP2011508790A5 (enExample) 2011-05-12
JP5197763B2 JP5197763B2 (ja) 2013-05-15

Family

ID=40636913

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010542439A Active JP5197763B2 (ja) 2008-04-18 2009-04-17 生物活性薬剤を含有するポリマーを含む医療用デバイスおよび方法
JP2013011995A Active JP5693623B2 (ja) 2008-04-18 2013-01-25 生物活性薬剤を含有するポリマーを含む医療用デバイスおよび方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013011995A Active JP5693623B2 (ja) 2008-04-18 2013-01-25 生物活性薬剤を含有するポリマーを含む医療用デバイスおよび方法

Country Status (10)

Country Link
US (2) US8557273B2 (enExample)
EP (2) EP3666255A1 (enExample)
JP (2) JP5197763B2 (enExample)
KR (1) KR20100054844A (enExample)
CN (2) CN103142459B (enExample)
AU (1) AU2009236094B2 (enExample)
BR (1) BRPI0904961A2 (enExample)
CA (1) CA2700561A1 (enExample)
RU (1) RU2521395C2 (enExample)
WO (1) WO2009129439A2 (enExample)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2691646T3 (es) 2005-07-15 2018-11-28 Micell Technologies, Inc. Revestimientos poliméricos que contienen polvo de fármaco de morfología controlada
WO2007011708A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
CA2996768C (en) 2006-04-26 2020-12-08 Micell Technologies, Inc. Coatings containing multiple drugs
JP5336382B2 (ja) 2006-10-23 2013-11-06 ミセル テクノロジーズ、インコーポレイテッド コーティングの間に基板を荷電するためのホルダー
CN101711137B (zh) 2007-01-08 2014-10-22 米歇尔技术公司 具有可生物降解层的支架
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
CN101815540B (zh) 2007-05-25 2015-08-19 米歇尔技术公司 用于医疗器材涂层的聚合物膜
CA2721832C (en) 2008-04-17 2018-08-07 Micell Technologies, Inc. Stents having bioabsorbable layers
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US8557273B2 (en) * 2008-04-18 2013-10-15 Medtronic, Inc. Medical devices and methods including polymers having biologically active agents therein
WO2010009335A1 (en) 2008-07-17 2010-01-21 Micell Technologies, Inc. Drug delivery medical device
US8834913B2 (en) 2008-12-26 2014-09-16 Battelle Memorial Institute Medical implants and methods of making medical implants
JP4526597B1 (ja) * 2009-01-26 2010-08-18 エンパイア テクノロジー ディベロップメント エルエルシー 細胞培養足場の製造方法
US20100239632A1 (en) 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
CN102481195B (zh) 2009-04-01 2015-03-25 米歇尔技术公司 涂覆支架
EP3366326A1 (en) 2009-04-17 2018-08-29 Micell Technologies, Inc. Stents having controlled elution
EP2453834A4 (en) 2009-07-16 2014-04-16 Micell Technologies Inc MEDICAL DEVICE DISPENSING MEDICINE
EP2531140B1 (en) 2010-02-02 2017-11-01 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
US9554830B2 (en) 2010-02-25 2017-01-31 Mayo Foundation For Medical Education And Research Delivering drugs to desired locations within a mammal
US8795762B2 (en) 2010-03-26 2014-08-05 Battelle Memorial Institute System and method for enhanced electrostatic deposition and surface coatings
EP2558101A4 (en) * 2010-04-15 2013-09-18 Univ Mcgill TOPICAL TREATMENTS OF PAIN
WO2011133655A1 (en) 2010-04-22 2011-10-27 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
WO2011133370A1 (en) * 2010-04-23 2011-10-27 Medtronic, Inc. Shelf stable pharmaceutical depot
US11033624B2 (en) 2010-06-02 2021-06-15 Novaflux Inc. Medical item for prevention and treatment of ear infection
US8747883B2 (en) * 2010-06-02 2014-06-10 Princeton Trade & Technology, Inc. Medical item for long term drug release
WO2012009684A2 (en) 2010-07-16 2012-01-19 Micell Technologies, Inc. Drug delivery medical device
CA2810842C (en) 2010-09-09 2018-06-26 Micell Technologies, Inc. Macrolide dosage forms
US20120142747A1 (en) * 2010-12-03 2012-06-07 Warsaw Orthopedic, Inc. Compositions and methods for delivering clonidine to a target tissue site
US9005634B2 (en) 2011-04-13 2015-04-14 Medtronic, Inc. Shelf stable pharmaceutical depot
WO2012166819A1 (en) 2011-05-31 2012-12-06 Micell Technologies, Inc. System and process for formation of a time-released, drug-eluting transferable coating
WO2012166934A1 (en) * 2011-06-01 2012-12-06 The Regents Of The University Of California Methods and compositions for the treatment of pain
EP2723357A4 (en) 2011-06-21 2015-04-01 Bvw Holding Ag MEDICAL DEVICE COMPRISING BOSWELLIC ACID
US10117972B2 (en) 2011-07-15 2018-11-06 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
WO2013142119A1 (en) 2012-03-20 2013-09-26 Trustees Of Tufts College Silk reservoirs for drug delivery
US9511018B2 (en) * 2012-04-05 2016-12-06 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable matrix
CN110269959A (zh) 2013-03-12 2019-09-24 脉胜医疗技术公司 可生物吸收的生物医学植入物
ITTO20130284A1 (it) * 2013-04-09 2014-10-10 Fond Istituto Italiano Di Tecnologia Procedimento per la produzione di microparticelle polimeriche sagomate
WO2014186532A1 (en) 2013-05-15 2014-11-20 Micell Technologies, Inc. Bioabsorbable biomedical implants
US10099035B2 (en) * 2014-04-22 2018-10-16 Medtronic Ardian Luxembourg S.A.R.L. Anti-resterilization components for catheter treatment devices and associated devices, systems, and methods
WO2015168642A1 (en) 2014-05-02 2015-11-05 Labib Mohamed E Drug-releasing device usable in mucosal body cavities
US9764122B2 (en) 2014-07-25 2017-09-19 Warsaw Orthopedic, Inc. Drug delivery device and methods having an occluding member
US9775978B2 (en) 2014-07-25 2017-10-03 Warsaw Orthopedic, Inc. Drug delivery device and methods having a retaining member
CN105560161B (zh) * 2014-10-09 2019-11-12 安徽中人科技有限责任公司 一种肾用地塞米松植入剂制备方法
CN104667346B (zh) * 2015-03-21 2016-09-14 杨青芳 一种可生物降解纳米微球的制备方法和应用
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
US20170065521A1 (en) * 2015-09-09 2017-03-09 Micell Technologies, Inc. Biopharma application of micell technology
TWI799366B (zh) 2015-09-15 2023-04-21 美商建南德克公司 胱胺酸結骨架平臺
US10076650B2 (en) 2015-11-23 2018-09-18 Warsaw Orthopedic, Inc. Enhanced stylet for drug depot injector
USD802755S1 (en) 2016-06-23 2017-11-14 Warsaw Orthopedic, Inc. Drug pellet cartridge
US10913930B2 (en) 2016-08-09 2021-02-09 Warsaw Orthopedic, Inc. Tissue processing apparatus and method for infusing bioactive agents into tissue
US10898447B2 (en) 2016-10-27 2021-01-26 Psirrros Inc. Finished pharmaceutical form with individual medicine dosing capability (embodiments) and methods of its production and use
US10434261B2 (en) 2016-11-08 2019-10-08 Warsaw Orthopedic, Inc. Drug pellet delivery system and method
US11357756B2 (en) 2017-01-20 2022-06-14 Warsaw Orthopedic, Inc. Anesthetic compositions and methods comprising imidazoline compounds
RU2671203C2 (ru) * 2017-01-30 2018-10-30 Общество с ограниченной ответственностью "Омские медицинские технологии" (ООО "ОММЕДТЕХ") Способ остеосинтеза переломов трубчатых костей
EP3691618A1 (en) 2017-10-06 2020-08-12 Foundry Therapeutics, Inc. Implantable depots for the controlled release of therapeutic agents
CN116650732A (zh) 2018-01-08 2023-08-29 铸造疗法股份有限公司 经由治疗剂的控制递送用于治疗腔内癌症的装置、系统和方法
CN108814667B (zh) * 2018-02-12 2020-12-11 东莞市奥慧捷医疗器械有限公司 一种皮下缝合钉及其制备方法
CN108814766B (zh) * 2018-03-15 2020-12-11 东莞市奥慧捷医疗器械有限公司 一种疝气补片固定钉及其制备方法
US12458589B2 (en) 2018-05-12 2025-11-04 Foundry Therapeutics, Inc. Implantable polymer depots for the controlled release of therapeutic agents
EP3843710A1 (en) 2018-08-28 2021-07-07 Foundry Therapeutics, Inc. Polymer implants
RU2721880C1 (ru) * 2019-07-09 2020-05-25 Федеральное государственное бюджетное учреждение науки Федеральный исследовательский центр химической физики им. Н.Н. Семенова Российской академии наук (ФИЦ ХФ РАН) Способ повышения регенерационного потенциала имплантируемого материала для восстановительной хирургии (варианты)
US12403291B2 (en) * 2019-08-30 2025-09-02 Intersect Ent, Inc. Submucosal bioresorbable drug eluting platform

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3020660A (en) 1959-11-30 1962-02-13 Scherotto John Collapsible imitation tree
US3202660A (en) 1961-10-09 1965-08-24 Boehringer Sohn Ingelheim Process for the preparation of 3-arylamino-1, 3-diazacycloalkenes
US4231938A (en) 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4621308A (en) 1984-01-16 1986-11-04 Rodney D. Holmberg Tackle box with light unit assembly
US4765974A (en) 1985-12-24 1988-08-23 Nitto Electric Industrial Co., Ltd. Preparation for percutaneous administration
US5175052A (en) 1988-05-11 1992-12-29 Nitto Denko Corporation Adhesive tape preparation of clonidine
US5077049A (en) * 1989-07-24 1991-12-31 Vipont Pharmaceutical, Inc. Biodegradable system for regenerating the periodontium
US5447947A (en) 1990-02-26 1995-09-05 Arc 1 Compositions and methods of treatment of sympathetically maintained pain
US5484607A (en) 1993-10-13 1996-01-16 Horacek; H. Joseph Extended release clonidine formulation
US5635204A (en) 1994-03-04 1997-06-03 Montefiore Medical Center Method for transdermal induction of anesthesia, analgesia or sedation
DE69603577T2 (de) * 1995-02-10 1999-11-25 Medtronic, Inc. Verfahren und vorrichtung zur verabreichung von analgetika
DE19542281C2 (de) 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
PL187926B1 (pl) 1996-03-25 2004-11-30 Lilly Co Eli Kompozycja farmaceutyczna do leczenia bólu
US6495579B1 (en) * 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
ATE318580T1 (de) 1996-12-20 2006-03-15 Alza Corp Gelzusammensetzungen und verfahren
US5801188A (en) 1997-01-08 1998-09-01 Medtronic Inc. Clonidine therapy enhancement
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US5942530A (en) 1997-08-28 1999-08-24 Eli Lilly And Company Method for treating pain
TW577758B (en) 1997-10-27 2004-03-01 Ssp Co Ltd Intra-articular preparation for the treatment of arthropathy
US6069129A (en) 1998-03-13 2000-05-30 Mrs, Llc Elastin derived composition and method of using same
US6179862B1 (en) 1998-08-14 2001-01-30 Incept Llc Methods and apparatus for in situ formation of hydrogels
US6632457B1 (en) 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
US6927044B2 (en) 1998-09-25 2005-08-09 Regeneron Pharmaceuticals, Inc. IL-1 receptor based cytokine traps
US6565874B1 (en) 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
US6143314A (en) 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6287588B1 (en) 1999-04-29 2001-09-11 Macromed, Inc. Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof
US6147102A (en) 1999-10-26 2000-11-14 Curatek Pharmaceuticals Holding, Inc. Clonidine preparations
US6461631B1 (en) 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
ES2232370T3 (es) 1999-11-29 2005-06-01 Novosis Ag Sistemas transdermicos para la administracion de clonidina.
US6287688B1 (en) 2000-03-03 2001-09-11 E. I. Du Pont De Nemours And Company Partially oriented poly(trimethylene terephthalate) yarn
US6589549B2 (en) 2000-04-27 2003-07-08 Macromed, Incorporated Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
JP2004511431A (ja) * 2000-06-28 2004-04-15 アトゥル・ジェイ・シュクラ 生物活性物質を含む生分解性ビヒクルおよび送達システム
US6417184B1 (en) 2000-09-19 2002-07-09 David M. Ockert Triple drug therapy for the treatment and prevention of acute or chronic pain
WO2002058730A2 (en) 2000-11-01 2002-08-01 Allergan, Inc. Compositions for treatment of ocular neovascularization
WO2002089794A1 (en) 2001-05-07 2002-11-14 Universite Catholique De Louvain Method for treating neuropathic pain and pharmaceutical preparation therefor
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Pharmaceuticals, Inc. Delivery of drug esters through an inhalation route
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
MXPA01011542A (es) 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
ATE507816T1 (de) * 2001-11-14 2011-05-15 Durect Corp Injizierbare depotzusammensetzungen und deren verwendung
US7345065B2 (en) 2002-05-21 2008-03-18 Allergan, Inc. Methods and compositions for alleviating pain
EP1531757B1 (en) 2002-07-19 2016-09-07 Omeros Corporation Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from
US7687080B2 (en) 2002-11-25 2010-03-30 Taraxos Inc. Treatment of neuropathy
US20050048099A1 (en) * 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US20040166088A1 (en) 2003-01-15 2004-08-26 Shalaby Shalaby W. Polymeric precursors of non-absorbable, in situ-forming hydrogels and applications thereof
US20040208917A1 (en) 2003-04-16 2004-10-21 Wilfried Fischer Transdermal systems for the release of clonidine
US20050079202A1 (en) * 2003-05-30 2005-04-14 Guohua Chen Implantable elastomeric depot compositions and uses thereof
US20040265364A1 (en) 2003-06-25 2004-12-30 Binnur Ozturk Neuropathy cream
US20050095277A1 (en) 2003-06-25 2005-05-05 Binnur Ozturk Neuropathy cream
US20050059744A1 (en) 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
US20050058696A1 (en) 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
CA2540895C (en) 2003-10-02 2016-08-02 Elan Pharmaceuticals, Inc. Combinations of ziconotide and opioids for reducing pain
WO2005046746A2 (en) 2003-11-10 2005-05-26 Angiotech International Ag Medical implants and fibrosis-inducing agents
JP2007519756A (ja) 2004-01-30 2007-07-19 アンジオテック インターナショナル アーゲー 拘縮を治療するための組成物および方法
US7232435B2 (en) * 2004-02-06 2007-06-19 Medtronic, Inc. Delivery of a sympatholytic cardiovascular agent to the central nervous system to counter heart failure and pathologies associated with heart failure
US7589057B2 (en) 2004-04-30 2009-09-15 Allergan, Inc. Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
US8685435B2 (en) 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
WO2006022611A2 (en) 2004-06-26 2006-03-02 Binnur Ozturk Neuropathy cream
US7294138B2 (en) 2004-06-28 2007-11-13 Shippert Ronald D Nose pack method and apparatus
US20060253100A1 (en) 2004-10-22 2006-11-09 Medtronic, Inc. Systems and Methods to Treat Pain Locally
CN101119713A (zh) 2004-11-24 2008-02-06 阿尔高克斯制药公司 类辣椒素凝胶制剂及其用途
US7611494B2 (en) 2005-02-08 2009-11-03 Confluent Surgical, Inc. Spray for fluent materials
US20060204548A1 (en) * 2005-03-01 2006-09-14 Allergan, Inc. Microimplants for ocular administration
US20060211665A1 (en) 2005-03-17 2006-09-21 Ranawat Chitranjan S Reduction of postoperative pain medication
WO2006127907A2 (en) 2005-05-25 2006-11-30 Massachusetts Institute Of Technology Localized delivery of cardiac inotropic agents
US9259267B2 (en) 2005-09-06 2016-02-16 W.L. Gore & Associates, Inc. Devices and methods for treating cardiac tissue
US20070104769A1 (en) 2005-11-04 2007-05-10 Lifescience Plus, Inc. Bioabsorbable hemostatic gauze
US10029034B2 (en) * 2005-12-15 2018-07-24 CARDINAL HEALTH SWITZERLAND 515 GmbH Drug-eluting articles with improved drug release profiles
US7610100B2 (en) 2005-12-30 2009-10-27 Boston Scientific Neuromodulation Corporation Methods and systems for treating osteoarthritis
US7741273B2 (en) 2006-04-13 2010-06-22 Warsaw Orthopedic, Inc. Drug depot implant designs
US8974542B2 (en) 2006-06-27 2015-03-10 University of Pittsburgh—of the Commonwealth System of Higher Education Biodegradable elastomeric patch for treating cardiac or cardiovascular conditions
US20080075777A1 (en) * 2006-07-31 2008-03-27 Kennedy Michael T Apparatus and methods for preparing solid particles
US20080095831A1 (en) * 2006-08-10 2008-04-24 Mc Graw Thomas L Topical formulation of multilamellar vesicles composition for percutaneous absorption of pharmaceutically active agent
US7671014B2 (en) 2006-08-14 2010-03-02 Warsaw Orthopedic, Inc. Flowable carrier matrix and methods for delivering to a patient
US20080091207A1 (en) 2006-10-13 2008-04-17 Csaba Truckai Bone treatment systems and methods
US20080152709A1 (en) 2006-12-22 2008-06-26 Drugtech Corporation Clonidine composition and method of use
WO2009100441A2 (en) 2008-02-08 2009-08-13 Impax Laboratories, Inc. Depot formulations
US8557273B2 (en) * 2008-04-18 2013-10-15 Medtronic, Inc. Medical devices and methods including polymers having biologically active agents therein

Similar Documents

Publication Publication Date Title
WO2009129439A4 (en) Medical devices and methods including polymers having biologically active agents therein
JP5923493B2 (ja) 注射可能なデポー組成物の調製方法
JP5882993B2 (ja) 抗精神病薬デポ型注射用組成物
KR101194894B1 (ko) 클로니딘을 포함하는 수술-후 통증 치료용 조성물
AU2006299657B2 (en) Sustained release small molecule drug formulation
US20160038655A1 (en) Methods and Devices For Three-Dimensional Printing Or Additive Manufacturing Of Bioactive Medical Devices
JP2013527213A5 (enExample)
US11185496B2 (en) Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
US20200030491A1 (en) Methods and Devices For Three-Dimensional Printing Or Additive Manufacturing Of Bioactive Medical Devices
HRP20140158T1 (hr) Formulacija paliperidon implantata
JP2015044823A5 (enExample)
AU2009236419A1 (en) Dexamethasone formulations in a biodegradable material
CN101522170A (zh) 在延长的一段时间里释放活性成分的皮下植入剂
EP2403482A1 (en) Abuse resistant formulation
HRP20220922T1 (hr) Usadive tablete naltreksona
EP2276459A2 (en) Sulindac formulations in a biodegradable material
JP2011508791A (ja) 生物分解性ポリマー担体中のフルオシノロン製剤
EP2485717B1 (en) Delivery system for sustained release of a calcium-channel blocking agent
CN101677946A (zh) 具有改善的掩味的挤出物
CN1316954C (zh) 一种植入式局部给药装置及其三维打印制备方法
DE3807523A1 (de) Oral verabreichbares system zur kontrollierten freigabe von wirkstoffen
CN101522169A (zh) 在延长的一段时间里释放活性成分的皮下植入剂
US20230080240A1 (en) Drug implants containing enzalutamide and methods of use thereof
CN102166371B (zh) 药物可控时序释放的含多种药物的磷酸钙骨水泥粉末
CN101553212A (zh) 在延长的一段时间里释放活性成分的皮下植入剂